Composite Bioelectrodes Based on Lipidic Cubic Phase with Carbon Nanotube Network

Enhanced transformation of organic pollutants by mild oxidants in the presence of synthetic or natural redox mediators: A review

Synthetic or natural mediators (Med) can enhance the transformation of different types of organic pollutants by mild oxidants, which has been extensively studied in literature. This enhancing effect is attributed to the following two steps: (i) mild oxidants react with Med forming Med_ox with higher reactivity, and then (ii) these organic pollutants are more readily transformed by Med_ox. The present work reviews the latest findings on the formation of Med_ox from the reactions of synthetic (i.e., 2,2'-azino-bis(3-ethylbenzothiazoline)-6-sulfonate (ABTS) and 1-hydroxybenzotriazole (HBT)) or natural mediators (i.e., syringaldehyde (SA), acetosyringone (AS), p-coumaric acid, and catechol) with mild oxidants such as laccase, manganese oxidants including permanganate (Mn(VII)) and MnO₂, and ferrate (Fe(VI)), as well as the transformation of organic pollutants including phenols, amines, polycyclic aromatic hydrocarbons (PAHs), organic dyes, pulp, and perfluoroalkyl acids (PFAAs) by Med_ox. First, reaction kinetics and mechanisms of the oxidation of synthetic or natural mediators by these mild oxidants were summarized. Reactivity and pathways of synthetic Med_ox including ABTS^·+, ABTS²⁺, HBT^· or natural Med_ox including phenoxy radicals and quinone-type compounds reacting with different organic pollutants were then discussed. Finally, the possibilities of engineering applications and new perspectives were assessed on the combinations of different types of mild oxidants with synthetic or natural mediators for the treatment of various organic pollutants.

Phytantriol based smart nano-carriers for drug delivery applications

From the last couple of decades, lyotropic liquid crystals have garnered enormous attentions in medical and pharmaceutical sciences. Non-toxic, chemically stable, and biocompatible properties of these liquid crystal systems are contributing to their applications for drug delivery. Among a large variety of liquid crystal phases, inverse bicontinuous cubic and inverse hexagonal mesophases have been extensively investigated for their ability to encapsulate and controlled release of bioactive molecules of various sizes and polarity. The concept of changing the drug release rate in situ by simply changing the mesophase structure is much more fascinating. The encapsulation of bioactive compounds in mesophase systems of desirable features in sub-micron sized particles such as hexosomes and cubosomes, at ambient and high temperature is bringing innovation in the development of new drug applications. This review article outlines unique structural features of cubosomes and hexosomes, their methods of productions, factors affecting their formations and their potential utilization as smart nano-carriers for biopharmaceuticals in drug delivery applications.

Cubosome Topologies at Various Particle Sizes and Crystallographic Symmetries

The nanoparticles built of bicontinuos lyotropic phases of cubic symmetry are studied within the framework of the Landau-Brazovskii functional that correctly predicts the structure of soft monocrystals and thin films of bicontinuos lyotropic phases. A detailed description of the geometry and topology of cubosomes is presented. This level of description of the internal structure of cubosomes is not easily accessible by experimental techniques. I show that the internal structure of the cubosomes may be extremely rich.

ABTS as an Electron Shuttle to Enhance the Oxidation Kinetics of Substituted Phenols by Aqueous Permanganate

In this study, it was, interestingly, found that 2,2'-azino-bis(3-ethylbenzothiazoline)-6-sulfonate (ABTS), a widely used electron shuttle, could greatly accelerate the oxidation of substituted phenols by potassium permanganate (Mn(VII)) in aqueous solutions at pH 5-9. This was attributed to the fact that these substituted phenols could be readily oxidized by the stable radical cation (ABTS(•+)), which was quickly produced from the oxidation of ABTS by Mn(VII). The reaction of Mn(VII) with ABTS exhibited second-order kinetics, with stoichiometries of ∼5:1 at pH 5-6 and ∼3:1 at pH 7-9, and the rate constants varied negligibly from pH 5 to 9 (k = (9.44 ± 0.21) × 10(4) M(-1) s(-1)). Comparatively, the reaction of ABTS(•+) with phenol showed biphasic kinetics. The second-order rate constants for the reactions of ABTS(•+) with substituted phenols obtained in the initial phase were strongly affected by pH, and they were several orders of magnitude higher than those for the reactions of Mn(VII) with substituted phenols at each pH. Good Hammett-type correlations were found for the reactions of ABTS(•+) with undissociated (log(k) = 2.82-4.31σ) and dissociated phenols (log(k) = 7.29-5.90σ). The stoichiometries of (2.2 ± 0.06):1 (ABTS(•+) in excess) and (1.38 ± 0.18):1 (phenol in excess) were achieved in the reaction of ABTS(•+) with phenol, but they exhibited no pH dependency.

Design and assembly of pH-sensitive lipidic cubic phase matrices for drug release

Bicontinuous lipidic cubic phases (LCPs) exhibit a combination of material properties that make them highly interesting for various biomaterial applications: they are nontoxic, biodegradable, optically transparent, thermodynamically stable in excess water, and can incorporate active molecules of virtually any polarity. Here we present a molecular system comprising host lipid, water, and designed lipidic additive, which form a structured, pH-sensitive lipidic matrix for hydrophilic as well as hydrophobic drug incorporation and release. The model drug doxorubicin (Dox) was loaded into the LCP. Tunable interactions with the lipidic matrix led to the observed pH-dependent drug release from the phase. The rate of Dox release from the cubic phase at pH 7.4 was low but increased significantly at more acidic pH. A small amount of a tailored diacidic lipid (lipid 1) added to the monoolein LCP modified the release rate of the drug. Phase identity and structural parameters of pure and doped mesophases were characterized by small-angle X-ray scattering (SAXS), and release profiles from the matrix were monitored electrochemically. Analysis of the release kinetics revealed that the total amount of drug released from the LCP matrix is linearly dependent on the square root of time, implying that the release mechanism proceeds according to the Higuchi model.

Recent Developments of Nanostructured Electrodes for Bioelectrocatalysis of Dioxygen Reduction

The recent development of nanostructured electrodes for bioelectrocatalytic dioxygen reduction catalysed by two copper oxidoreductases, laccase and bilirubin oxidase, is reviewed. Carbon-based nanomaterials as carbon nanotubes or carbon nanoparticles are frequently used for electrode modification, whereas there are only few examples of biocathodes modified with metal or metal oxide nanoparticles. These nanomaterials are adsorbed on the electrode surface or embedded in multicomponent film. The nano-objects deposited act as electron shuttles between the enzyme and the electrode substrate providing favourable conditions for mediatorless bioelectrocatalysis.